Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Cash & Equivalents (2016 - 2026)

MedWellAI has reported Cash & Equivalents over the past 12 years, most recently at $137503.0 for Q4 2025.

  • Quarterly Cash & Equivalents fell 41.37% to $137503.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $137503.0 through Dec 2025, down 41.37% year-over-year, with the annual reading at $401310.0 for FY2025, 594.13% up from the prior year.
  • Cash & Equivalents was $137503.0 for Q4 2025 at MedWellAI, down from $223221.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $2.1 million in Q2 2021 and troughed at $27452.0 in Q4 2023.
  • The 5-year median for Cash & Equivalents is $228870.0 (2024), against an average of $355485.2.
  • Year-over-year, Cash & Equivalents skyrocketed 31323.78% in 2021 and then plummeted 79.47% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $155729.0 in 2021, then tumbled by 44.2% to $86891.0 in 2022, then tumbled by 68.41% to $27452.0 in 2023, then skyrocketed by 754.29% to $234519.0 in 2024, then tumbled by 41.37% to $137503.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Cash & Equivalents are $137503.0 (Q4 2025), $223221.0 (Q3 2025), and $401310.0 (Q2 2025).